Pharmaceutical Technology, May 2022

Resolving operational bottlenecks makes mAb manufacturing more efficient.

Researchers demonstrated a new cell lysis method using a novel solution to improve viral vector production.

Inhalation formulations are complex, and empirical data are essential for realizing optimal solutions.

Advances in therapeutic modalities and an increase in molecular complexity have led to the need for an evolution in drug delivery approaches over the years.

Ongoing advances in technology and modeling techniques are helping to align all the objectives of both drug manufacturers and patients.

Using more exacting analytical tools can give a clearer assessment of gene-editing outcomes.

Digital maintenance solutions can help visualize the value and key activities provided by the equipment vendor from inception to utilization.

With the majority of large pharmaceutical manufacturers aiming for carbon neutrality by 2030, reusable packaging remains a largely untapped approach in achieving measurable ESG gains.

Establishing a quality culture from the top of an organization down to each and every employee ensures a safe and effective product, and saves costs.

This article provides best practice to avoid errors in weighing by difference caused by buoyancy and drift.

Recent trends in dissolution testing have led to increased use of data integrity solutions and more biorelevant testing techniques.

Partnering with an experienced service provider can help companies unlock the commercial potential of new therapeutic approaches.

On 26 May 2022, the European Commission will roll-out the new in-vitro diagnostic regulation.

A long-running criminal case involving the theft of confidential data from a pharma giant is still unravelling, as more convictions are made.

What are the next steps for permanent authorization of COVID-19 vaccines, treatments, and diagnostics?

Fresh insight is instrumental in the discussion of novel analytics.

Process validation for a drug product must be done with commercial scale batches, says Siegfried Schmitt, vice president, Technical at Parexel.

The Spheronizer from DIOSNA Dierks & Söhne is designed for the granulation and pelletizing of particles during the development of oral solid dosage forms.

Sepha’s EZ Blister+ is a compact small-batch blister packaging machine that is 21 CFR Part 11 compliant.

The KTEvolution from Tower Cold Chain is a lightweight, reusable container designed for the transport of pharmaceutical products.

ROSS incorporated a high shear rotor/stator into its Dual-Shaft Mixer to meet more intense shearing and homogenization requirements.

Spring has returned, and with it comes INTERPHEX.